CollPlant Announces Agreement with Allergan Aesthetics for rhCollagen in Filler Products

Posted By American Med Spa Association, Monday, February 8, 2021

CollPlant Biotechnologies has announced it has entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with Allergan Aesthetics, an AbbVie company.
CollPlant has granted Allergan Aesthetics worldwide exclusivity to use its plant-derived recombinant human collagen (rhCollagen) in combination with Allergan Aesthetics' proprietary technologies, for the production and commercialization of dermal and soft tissue fillers. In addition, Allergan Aesthetics has the right of first negotiation for CollPlant's technology in two future additional products.
Read more at PR Newswire >>